DCF — OSU MEDICAL CENTER
Enterprise Value: $-126.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-126.2M
Enterprise Value
$-42.2M
PV of Cash Flows
$-84.0M
PV of Terminal Value
$-135.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $147.0M | $-6.6M | -4.0% | $-12.8M | $-11.7M |
| Year 2 | $151.4M | $-5.3M | -3.0% | $-11.7M | $-9.7M |
| Year 3 | $156.0M | $-3.9M | -2.0% | $-10.5M | $-7.9M |
| Year 4 | $160.6M | $-3.2M | -2.0% | $-10.0M | $-6.8M |
| Year 5 | $165.5M | $-2.9M | -2.0% | $-9.9M | $-6.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-126.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$142.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999999649695634
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5